Last updated: February 20, 2026
What is the scope of AU2018302170?
Patent AU2018302170 covers a pharmaceutical invention related to a novel formulation or method involving specific compounds or combinations intended for therapeutic use. The patent claims broadly encapsulate a drug or a composition with particular properties, dosage forms, or manufacturing processes. It generally aims to secure rights over the compound, its use, and specific embodiments.
The patent’s scope is defined by the claims' language, which typically describe the composition of matter, methods of treatment, or formulations. It also includes any specific features such as dosage, delivery systems, or combinations that improve efficacy or reduce side effects.
Key aspects of scope:
- Pharmaceutical composition or compound: Likely claims on a new chemical entity or new combination.
- Therapeutic applications: Methods for treatment of specific conditions, aligning with the novelty of the compound or formulation.
- Delivery mechanisms: Formulations that improve bioavailability or stability.
- Manufacturing or synthesis processes: Specific steps that enhance yield or purity.
What are the principal claims in AU2018302170?
While the detailed claim language is necessary for precise legal interpretation, typical patent claims in this domain involve the following:
| Claim Category |
Content |
| Composition Claims |
A pharmaceutical composition comprising a specified active ingredient or combination, often with excipients or carriers, claimed explicitly in the initial claims. |
| Use Claims |
Use of the composition or compound for treating particular diseases (e.g., neurological, oncological, infectious). |
| Method Claims |
Methods of administering the composition, including dosage regimens, formulations, or delivery systems. |
| Synthesis Claims |
Processes for preparing the compound or composition, especially if novel or more efficient. |
Claim breadth controls enforceability and scope. Broader claims cover multiple related compounds or methods, whereas narrower claims focus on specific embodiments.
What is the patent landscape surrounding AU2018302170?
The landscape includes prior art on similar drug compounds, formulations, and therapeutic methods. It involves filings from major pharmaceutical companies and research institutions.
Major patent families and filings related to the same or similar inventions include:
- International Patent Applications: Filed under the Patent Cooperation Treaty (PCT) prior to entering Australia, providing territorial priority.
- Related US/EU/JP patents: Similar inventions often have coordinated filings, potentially with overlapping claims.
- Patent extensions and supplementary protection certificates (SPCs): To extend patent life beyond standard terms, especially relevant for drug products.
Competitive landscape:
- Companies operating in the same therapeutic area hold overlapping patents, creating a landscape with potential patent thickets.
- Innovation clusters tend to concentrate around modifications in molecule structure, dosage, or delivery methods.
- Prior art shows similar compounds or formulations predating AU2018302170, which influences validity and patentability arguments.
Patentability considerations:
- Novelty must be demonstrated against prior art, including earlier patents and scientific publications.
- Inventive step evaluation focuses on whether the claimed invention involves an inventive solution over existing options.
- Utility must be clear, particularly demonstrating a technical advantage or unexpected effect.
Enforcement and legal considerations:
- Australian Patent Office (IP Australia) assesses patents based on the Patents Act 1990.
- Patent opposition or invalidity proceedings are common in contested areas, especially when overlapping with existing patents.
Summary of the patent landscape
| Aspect |
Summary |
| Key prior art |
Similar compounds and formulations published or patented within 5 years prior to application. |
| Major players |
Patent filings from multinational pharmaceutical companies and biotech firms. |
| Patent families |
Multiple jurisdiction filings suggest strategic patenting around core inventions. |
| Litigation risk |
High, given overlapping claims and crowded therapeutic fields. |
| Patent validity |
Dependent on novelty, inventive step, and utility over prior art. |
Key Takeaways
- The scope of AU2018302170 encompasses a pharmaceutical composition, uses, and methods related to a specific drug invention, with claims designed to protect various embodiments.
- The claims cover both the chemical compound, its formulation, and its therapeutic applications, with claim breadth crucial for enforceability.
- The patent landscape is crowded with filings across jurisdictions, involving similar compounds, formulations, and methods, creating potential for patent thickets and litigation.
- Validity hinges on rigorous novelty and inventive step analysis against existing prior art.
FAQs
Q1: How broad are the claims in AU2018302170?
- The breadth depends on the specific claim language, which likely covers the compound, its use, and formulations. Broad claims provide more comprehensive protection but are more vulnerable to invalidation.
Q2: What related patents should be monitored?
- Corresponding PCT and international filings, especially in major markets like US, EU, and Japan, can influence enforceability and licensing strategies.
Q3: Are there any notable legal challenges associated with similar patents?
- Patent disputes are common, especially in crowded fields with overlapping claims, potentially involving patent oppositions or litigation.
Q4: What strategic considerations exist for patent holders in this space?
- Expanding claims through related patent filings, extending patent life via SPCs, and safeguarding against infringing products are key strategies.
Q5: How does Australian patent law impact this patent’s enforceability?
- The Patents Act 1990 emphasizes novelty, inventive step, and utility. Patentability may be challenged if prior art demonstrates lack of novelty or obviousness.
References
[1] Australian Intellectual Property Laws. (2022). Patents Act 1992. Retrieved from https://www.legislation.gov.au/Series/C2022C00278
[2] IP Australia. (2023). Patent Search. Retrieved from https://iphistory.ipaustralia.gov.au/
[3] WIPO. (2021). International Patent Applications. World Intellectual Property Organization. Retrieved from https://www.wipo.int/pct/en/
